• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类和鼠类 MPL P106L 的不完全转运缺陷导致细胞表面的矛盾性血小板增多症。

An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106L.

机构信息

INSERM, UMR 1170, Équipe labellisée Ligue Nationale contre le Cancer, Gustave Roussy, Villejuif, France.

Université Paris-Saclay, UMR 1170 Équipe labellisée par le GrEx, Gustave Roussy, Villejuif, France.

出版信息

Blood. 2016 Dec 29;128(26):3146-3158. doi: 10.1182/blood-2016-06-722058. Epub 2016 Nov 10.

DOI:10.1182/blood-2016-06-722058
PMID:28034873
Abstract

The mechanisms behind the hereditary thrombocytosis induced by the thrombopoietin (THPO) receptor MPL P106L mutant remain unknown. A complete trafficking defect to the cell surface has been reported, suggesting either weak constitutive activity or nonconventional THPO-dependent mechanisms. Here, we report that the thrombocytosis phenotype induced by MPL P106L belongs to the paradoxical group, where low MPL levels on platelets and mature megakaryocytes (MKs) lead to high serum THPO levels, whereas weak but not absent MPL cell-surface localization in earlier MK progenitors allows response to THPO by signaling and amplification of the platelet lineage. MK progenitors from patients showed no spontaneous growth and responded to THPO, and MKs expressed MPL on their cell surface at low levels, whereas their platelets did not respond to THPO. Transduction of MPL P106L in CD34 cells showed that this receptor was more efficiently localized at the cell surface on immature than on mature MKs, explaining a proliferative response to THPO of immature cells and a defect in THPO clearance in mature cells. In a retroviral mouse model performed in Mpl mice, MPL P106L could induce a thrombocytosis phenotype with high circulating THPO levels. Furthermore, we could select THPO-dependent cell lines with more cell-surface MPL P106L localization that was detected by flow cytometry and [I]-THPO binding. Altogether, these results demonstrate that MPL P106L is a receptor with an incomplete defect in trafficking, which induces a low but not absent localization of the receptor on cell surface and a response to THPO in immature MK cells.

摘要

导致血小板生成素(THPO)受体 MPL P106L 突变引起遗传性血小板增多的机制尚不清楚。据报道,存在完全的细胞表面转运缺陷,提示存在弱组成性活性或非常规的 THPO 依赖性机制。在这里,我们报告 MPL P106L 诱导的血小板增多表型属于矛盾组,其中血小板和成熟巨核细胞(MK)上的低 MPL 水平导致高血清 THPO 水平,而早期 MK 祖细胞中较弱但并非不存在的 MPL 细胞表面定位允许通过信号传导和血小板谱系的放大对 THPO 作出反应。来自患者的 MK 祖细胞没有自发生长,并对 THPO 作出反应,MK 表面表达低水平的 MPL,而其血小板对 THPO 无反应。在 CD34 细胞中转导 MPL P106L 表明,该受体在不成熟的 MK 上比在成熟的 MK 上更有效地定位在细胞表面,这解释了不成熟细胞对 THPO 的增殖反应和成熟细胞中 THPO 清除的缺陷。在 Mpl 小鼠中进行的逆转录病毒小鼠模型中,MPL P106L 可诱导高循环 THPO 水平的血小板增多表型。此外,我们可以通过流式细胞术和[I]-THPO 结合检测到更多细胞表面 MPL P106L 定位,从而选择依赖 THPO 的细胞系。总之,这些结果表明 MPL P106L 是一种转运不完全缺陷的受体,它在细胞表面诱导低但并非不存在的受体定位,并在不成熟的 MK 细胞中对 THPO 作出反应。

相似文献

1
An incomplete trafficking defect to the cell-surface leads to paradoxical thrombocytosis for human and murine MPL P106L.人类和鼠类 MPL P106L 的不完全转运缺陷导致细胞表面的矛盾性血小板增多症。
Blood. 2016 Dec 29;128(26):3146-3158. doi: 10.1182/blood-2016-06-722058. Epub 2016 Nov 10.
2
The thrombopoietin receptor P106L mutation functionally separates receptor signaling activity from thrombopoietin homeostasis.血小板生成素受体 P106L 突变在功能上使受体信号活性与血小板生成素的内稳定分离。
Blood. 2015 Feb 12;125(7):1159-69. doi: 10.1182/blood-2014-07-587170. Epub 2014 Dec 23.
3
Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.在mpl基因敲除小鼠中,Mpl表达的不完全恢复可部分纠正干细胞重建缺陷并导致矛盾性血小板增多症。
Blood. 2009 Feb 19;113(8):1778-85. doi: 10.1182/blood-2007-11-124859. Epub 2008 Sep 16.
4
Calreticulin mutants in mice induce an MPL-dependent thrombocytosis with frequent progression to myelofibrosis.钙网织蛋白突变小鼠诱导 MPL 依赖性血小板增多症,并常进展为骨髓纤维化。
Blood. 2016 Mar 10;127(10):1317-24. doi: 10.1182/blood-2015-11-679571. Epub 2015 Nov 25.
5
Inhibition of Thrombopoietin/Mpl Signaling in Adult Hematopoiesis Identifies New Candidates for Hematopoietic Stem Cell Maintenance.抑制成人造血过程中的血小板生成素/Mpl信号通路可鉴定出血液干细胞维持的新候选因子。
PLoS One. 2015 Jul 6;10(7):e0131866. doi: 10.1371/journal.pone.0131866. eCollection 2015.
6
Pro106Leu MPL mutation is associated with thrombocytosis and a low risk of thrombosis, splenomegaly and marrow fibrosis.Pro106Leu MPL突变与血小板增多症以及血栓形成、脾肿大和骨髓纤维化的低风险相关。
Platelets. 2022 Nov 17;33(8):1220-1227. doi: 10.1080/09537104.2022.2091773. Epub 2022 Jul 5.
7
Advances in megakaryocytopoiesis and thrombopoiesis: from bench to bedside.巨核细胞生成和血小板生成的进展:从基础到临床。
Br J Haematol. 2013 Jun;161(6):778-93. doi: 10.1111/bjh.12328. Epub 2013 Apr 18.
8
Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.在血小板和终末分化巨核细胞中表达水平降低的Mpl的转基因小鼠中出现明显的血小板增多症。
Blood. 2009 Feb 19;113(8):1768-77. doi: 10.1182/blood-2008-03-146084. Epub 2008 Oct 9.
9
Familial thrombocytosis caused by the novel germ-line mutation p.Pro106Leu in the MPL gene.由MPL基因中的新型种系突变p.Pro106Leu引起的家族性血小板增多症。
Br J Haematol. 2009 Jan;144(2):185-94. doi: 10.1111/j.1365-2141.2008.07430.x. Epub 2008 Nov 19.
10
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia.在 8 个意大利遗传性血小板增多症家系中发现 MPL-S505N 突变的 founder 效应。
Haematologica. 2009 Oct;94(10):1368-74. doi: 10.3324/haematol.2009.005918. Epub 2009 Jul 16.

引用本文的文献

1
Autophagosome-lysosome mediated secretion of the thrombopoietin receptor is modulated by distinct driver mutations of myeloproliferative neoplasm.自噬体-溶酶体介导的血小板生成素受体分泌受骨髓增殖性肿瘤不同驱动突变的调节。
Leukemia. 2025 Jul 3. doi: 10.1038/s41375-025-02676-6.
2
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis.ANKRD26 是正常和病理造血中 I 型细胞因子受体信号的新调节剂。
Haematologica. 2023 Aug 1;108(8):2130-2145. doi: 10.3324/haematol.2022.282049.
3
In and out: Traffic and dynamics of thrombopoietin receptor.
进出:血小板生成素受体的运输和动力学。
J Cell Mol Med. 2021 Oct;25(19):9073-9083. doi: 10.1111/jcmm.16878. Epub 2021 Aug 27.
4
Functional Consequences of Mutations in Myeloproliferative Neoplasms.骨髓增殖性肿瘤中突变的功能后果
Hemasphere. 2021 Jun 1;5(6):e578. doi: 10.1097/HS9.0000000000000578. eCollection 2021 Jun.
5
The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN.血小板生成素受体MPL是骨髓增殖性肿瘤中一个可利用的治疗靶点。
Front Oncol. 2021 Mar 10;11:641613. doi: 10.3389/fonc.2021.641613. eCollection 2021.
6
C-Cbl regulates c-MPL receptor trafficking and its internalization.C-Cbl 调节 c-MPL 受体的运输及其内化。
J Cell Mol Med. 2020 Nov;24(21):12491-12503. doi: 10.1111/jcmm.15785. Epub 2020 Sep 20.
7
Thrombopoietin is required for full phenotype expression in a JAK2V617F transgenic mouse model of polycythemia vera.血小板生成素对于 JAK2V617F 转基因小鼠模型真性红细胞增多症的完全表型表达是必需的。
PLoS One. 2020 Jun 1;15(6):e0232801. doi: 10.1371/journal.pone.0232801. eCollection 2020.
8
Identification of R102P Mutation in Hereditary Thrombocytosis.遗传性血小板增多症中R102P突变的鉴定
Front Endocrinol (Lausanne). 2017 Sep 20;8:235. doi: 10.3389/fendo.2017.00235. eCollection 2017.
9
Genetic Alterations of the Thrombopoietin/MPL/JAK2 Axis Impacting Megakaryopoiesis.影响巨核细胞生成的血小板生成素/MPL/JAK2轴的基因改变
Front Endocrinol (Lausanne). 2017 Sep 12;8:234. doi: 10.3389/fendo.2017.00234. eCollection 2017.
10
The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin.血小板生成素受体:配体、突变、激动剂及突变型钙网蛋白介导的转运与激活的结构基础
Front Endocrinol (Lausanne). 2017 Mar 31;8:59. doi: 10.3389/fendo.2017.00059. eCollection 2017.